“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online Jan. 8 in JAMA Network Open. Karen B.

Three-quarters of infants were exposed to the maternal RSV vaccine or nirsevimab during their first RSV season. Younger mothers and Black mothers were less likely to receive the maternal vaccine.

Something else to pay attention to is how the child is breathing, which could indicate the infection has moved.

A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led to a tenfold increase in the number of infants in that group that ...

Abrysvo also has been approved for the immunization of pregnant women at 32 through 36 weeks gestational age to prevent LRTD and to prevent severe LRTD from RSV in infants from birth through age 6 ...

Almost 70 years after the discovery of the respiratory syncytial virus (RSV), vaccines and preventive treatments are giving babies a chance to beat the potentially deadly childhood infection.

Hamilton Health Sciences is issuing a reminder that immunizations for respiratory syncytial virus (RSV) are available for infants less than a year old after seeing a rise in cases over the holiday ...

However, RSV can develop into severe infections, especially for premature babies, infants, older adults and those with heart and lung disease or weak immune systems. RSV is the most common cause ...

The analysis included electronic medical record data among 17,251 infants born to mothers aged 15 to 49 years. HealthDay News — Eight in 10 infants received respiratory syncytial virus (RSV ...